OnKure Therapeutics, Inc. (OKUR) financials · rev $3.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
OnKure Therapeutics, Inc. (OKUR) rev $3.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $3.44M | N/A |
| Operating Income | -$63.0M | -$54.4M |
| Net Income | -$59.5M | -$52.7M |
| EPS (Diluted) | -$4.40 | -$15.28 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $62.1M | $114.9M |
| Current Assets | $60.8M | $113.0M |
| Cash & Equivalents | $59.0M | $110.8M |
| PP&E | $618.0K | $1.02M |
| Total Liabilities | $5.93M | $11.1M |
| Current Liabilities | $5.92M | $10.5M |
| Shareholders' Equity | $56.2M | $103.8M |
| Retained Earnings | -$214.2M | -$154.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$51.8M | -$51.1M |
| CapEx | $46.0K | $52.0K |
| Investing Cash Flow | -$46.0K | $15.9M |
| Financing Cash Flow | $163.0K | $116.1M |
| Net Change in Cash | -$51.7M | $80.9M |
| Free Cash Flow | -$51.9M | -$51.2M |
FAQ
What is OKUR P/E and revenue?
OnKure Therapeutics, Inc. (OKUR) rev $3.4M.
What is OKUR revenue?
OnKure Therapeutics, Inc. last cached revenue is $3.44M (FY2025).
Is OKUR profitable?
OnKure Therapeutics, Inc. last cached net income is -$59.5M (FY2025).
What are OKUR total assets?
OnKure Therapeutics, Inc. last cached total assets are $62.1M (FY2025).
What is OKUR free cash flow?
OnKure Therapeutics, Inc. last cached free cash flow is -$51.9M (FY2025).
Not investment advice. Cached statements, not a live tape.